40
Participants
Start Date
July 20, 2016
Primary Completion Date
July 31, 2027
Study Completion Date
July 31, 2027
Bevacizumab
Quality-of-Life Assessment
Ancillary studies
Radiation Therapy
Undergo radiation therapy with conventional fractionation
M D Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER